nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia
|
Kapralova, Katarina |
|
|
128 |
10 |
p. 1418-1423 |
artikel |
2 |
Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy
|
Sun, Dongmei |
|
|
128 |
10 |
p. 1329-1335 |
artikel |
3 |
Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL
|
Daver, Naval |
|
|
128 |
10 |
p. 1316-1317 |
artikel |
4 |
Dausset J, Colombani J, Legrand L, Feingold N, Rapaport FT. Genetic and biological aspects of the HL-A system of human histocompatibility. Blood. 1970;35(5):591-612.
|
|
|
|
128 |
10 |
p. 1313 |
artikel |
5 |
Editorial Board
|
|
|
|
128 |
10 |
p. i |
artikel |
6 |
Epstein-Barr virus associated with a lymphoma-mimicking lesion of the uterine cervix
|
Okamura, Ikue |
|
|
128 |
10 |
p. 1439 |
artikel |
7 |
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation
|
Sarvaria, Anushruti |
|
|
128 |
10 |
p. 1346-1361 |
artikel |
8 |
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
|
Elena, Chiara |
|
|
128 |
10 |
p. 1408-1417 |
artikel |
9 |
Maude SL, Teachey DT, Porter DL, Grupp SA. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015;125(26):4017-4023.
|
|
|
|
128 |
10 |
p. 1441 |
artikel |
10 |
miR-146b antagomir–treated human Tregs acquire increased GVHD inhibitory potency
|
Lu, Yunjie |
|
|
128 |
10 |
p. 1424-1435 |
artikel |
11 |
Nodal marginal zone mutational signature
|
Piris, Miguel A. |
|
|
128 |
10 |
p. 1315-1316 |
artikel |
12 |
PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma
|
Miyoshi, Hiroaki |
|
|
128 |
10 |
p. 1374-1381 |
artikel |
13 |
Putting it all together in CMML risk stratification
|
Steensma, David P. |
|
|
128 |
10 |
p. 1318-1319 |
artikel |
14 |
Qin H, Cho M, Haso W, et al. Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein. Blood. 2015;126(5):629-639.
|
|
|
|
128 |
10 |
p. 1441 |
artikel |
15 |
Survival in adults with sickle cell disease in a high-income setting
|
Gardner, Kate |
|
|
128 |
10 |
p. 1436-1438 |
artikel |
16 |
Targeting Epstein-Barr virus–transformed B lymphoblastoid cells using antibodies with T-cell receptor–like specificities
|
Lai, Junyun |
|
|
128 |
10 |
p. 1396-1407 |
artikel |
17 |
Teachey DT, Rheingold SR, Maude SL, et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy. Blood. 2013;121(26):5154-5157.
|
|
|
|
128 |
10 |
p. 1441 |
artikel |
18 |
tfec controls the hematopoietic stem cell vascular niche during zebrafish embryogenesis
|
Mahony, Christopher B. |
|
|
128 |
10 |
p. 1336-1345 |
artikel |
19 |
The genetics of nodal marginal zone lymphoma
|
Spina, Valeria |
|
|
128 |
10 |
p. 1362-1373 |
artikel |
20 |
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia
|
Leblond, Véronique |
|
|
128 |
10 |
p. 1321-1328 |
artikel |
21 |
Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality
|
Li, Weijie |
|
|
128 |
10 |
p. 1440 |
artikel |
22 |
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
|
Khaw, Seong Lin |
|
|
128 |
10 |
p. 1382-1395 |
artikel |
23 |
Zeiser R, Blazar BR. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood. 2016;127(25):3117-3126.
|
|
|
|
128 |
10 |
p. 1441 |
artikel |